The BioLife Solutions Inc. (BLFS) Coverage Initiated by Analysts at Maxim Group

The BioLife Solutions Inc. (BLFS) Coverage Initiated by Analysts at Maxim Group

Maxim Group began coverage on shares of BioLife Solutions Inc. (NASDAQ:BLFS) in a report issued on Thursday. The firm set a “buy” rating and a $3.00 price target on the stock. Maxim Group’s target price points to a potential upside of 75.45% from the stock’s current price.

BioLife Solutions (NASDAQ:BLFS) opened at 1.7099 on Thursday. BioLife Solutions has a 52-week low of $1.43 and a 52-week high of $3.58. The firm has a 50-day moving average of $1.64 and a 200 day moving average of $1.75. The company’s market capitalization is $22.02 million.

BioLife Solutions (NASDAQ:BLFS) last posted its quarterly earnings results on Thursday, November 10th. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.01. BioLife Solutions had a negative net margin of 59.91% and a negative return on equity of 57.51%. The business earned $2.10 million during the quarter, compared to analyst estimates of $2.20 million. Equities analysts predict that BioLife Solutions will post ($0.35) earnings per share for the current fiscal year.

About BioLife Solutions

BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.

Related posts

Leave a Comment